View Single Post
Old 11-03-2017, 10:30 AM   Nav to Top 
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 227
Favorites: Aapl celg onxx
Rep Power: 102
Reputation: 36
Biohero is on a distinguished road
Default

Great time to load up nowafter they resubmit the NDA for Rizaport early this week .GL

RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines..November 1, 2017
https://finance.yahoo.com/news/redhi...110100087.html


Market Cap : US$48 Million / Cash US$8.2 million /very low burn-rate of ~$700K a Quarter =Cash untill 2020+ EXCLUDING payments from new partnerships ,profitability expected quickly with approval for Rizaport and Tadalafil both approval expected in 2018, if everything goes well then this stock could run to $10 even then it wouldnt be expensive .


Intelgenx (IGXT)

Markt-Cap $48 Million
Cash 8.1 Million
Price: $0.73


FDA Decision for Rizaport(Migraine) in Q2/2018 (Peak Sales $60-80 Million)


NDA submission for Tadalafil (erectile dysfunction) this Quarter >> FDA approval in 2H 2018 (Peak Sales $150++ Million)


Start Phase 2a for Montulukast (Alzheimer disease) this Quarter >> Phase 2a Results in 1H/2018 (Potential BLOCKBUSTER Drug)


Opioid dependence drug partnered with Par Pharma >> FDA approval depends on patent ruling (Peak Sales $100++ Million) 30-Month Stay already expired



MEGA Pipeline
http://s2.q4cdn.com/790425727/files/...-July-2017.jpg


Presentation
http://s2.q4cdn.com/790425727/files/...2017_final.pdf


https://investorintel.com/sectors/bi...n-film-market/
Biohero is offline   Rate this post Yes | No Reply With Quote